Ashton Thomas Private Wealth LLC Purchases 68 Shares of Danaher Co. (NYSE:DHR)

Ashton Thomas Private Wealth LLC increased its holdings in shares of Danaher Co. (NYSE:DHR) by 1.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 5,365 shares of the conglomerate’s stock after acquiring an additional 68 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Danaher were worth $1,492,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the business. Verus Capital Partners LLC purchased a new stake in shares of Danaher in the third quarter valued at approximately $203,000. WealthPlan Investment Management LLC grew its stake in Danaher by 28.4% in the third quarter. WealthPlan Investment Management LLC now owns 26,436 shares of the conglomerate’s stock valued at $7,350,000 after purchasing an additional 5,842 shares during the last quarter. Harbour Investments Inc. raised its stake in shares of Danaher by 3.0% during the 3rd quarter. Harbour Investments Inc. now owns 1,531 shares of the conglomerate’s stock worth $426,000 after acquiring an additional 45 shares in the last quarter. Entropy Technologies LP purchased a new stake in Danaher during the third quarter valued at approximately $6,701,000. Finally, Apollon Wealth Management LLC grew its holdings in Danaher by 1.3% in the third quarter. Apollon Wealth Management LLC now owns 21,915 shares of the conglomerate’s stock worth $6,093,000 after purchasing an additional 272 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of several recent analyst reports. Stifel Nicolaus increased their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Robert W. Baird lowered their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. The Goldman Sachs Group raised their price objective on shares of Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. KeyCorp lifted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Finally, UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Up 0.8 %

Shares of NYSE DHR opened at $241.47 on Thursday. The firm’s 50 day moving average price is $263.88 and its 200 day moving average price is $260.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a market cap of $174.41 billion, a P/E ratio of 46.08, a price-to-earnings-growth ratio of 4.40 and a beta of 0.85. Danaher Co. has a 1 year low of $200.36 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 earnings per share. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s payout ratio is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.